The history and modern approaches to clinical use of antihistaminic drugs

Emel’yanov A.V.; Kochergin N.G.; Goriachkina L.A.

doi:https://doi.org/

Emel’yanov A.V.

Department of Cardiovascular Surgery, Russian Cardiology Research and Production Complex, Moscow, Russia

Kochergin N.G.

I.M. Sechenov Moscow Medical Academy

Goriachkina L.A.

Russian Medical Academy of Postgraduate Education

The history and modern approaches to clinical use of antihistaminic drugs

Authors:

Emel’yanov A.V., Kochergin N.G., Goriachkina L.A.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2010;8(4): 62‑70

Read: 10806 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Emel’yanov AV, Kochergin NG, Goriachkina LA. The history and modern approaches to clinical use of antihistaminic drugs. Russian Journal of Clinical Dermatology and Venereology. 2010;8(4):62‑70. (In Russ.)

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)

Использование инфографики авторами научных работ

References:

Bovet D., Staub A.M. Action protective de ethers phenoliques au cours de l'ntoxication histaminique. Compt Rend Soc Biol 1937; 124: 547-549.
Staub A.M., Bovet D. Action de la thymoxyethyldiethylamine (925 F) et des ethers phenoliquers sur le choc anaphylactique du cobaye. Com Rend Soc Biol 1937; 125: 818-823.
Holgate S.T., Canonica G.W., Simons F.E.R. et al. Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations. Clin Exp Allergy 2003; 33: 1305-1324.
Simons F.E.R. Advances in H1-Antihistamines. N Engl J Med 2004; 351: 2203-2217.
Simons F.E.R., Akdis C. Histamine and H1-Antihistamines. Middleton's Allergy: Principles and Practice, 7th Edition.
N.F Adkinson, W.W. Busse, B.S. Bochner et al. Elsiver 2010; 2: 1517-1543.
Leurs R., Church M.K., Taglialatela M. H1-antihistamines: inverse agonism, antiinflammatory actions and cardiac effects. Clin Exp Allergy 2002; 32: 489-498.
Horak F., Stubner U.P., Zieglmayer R., Harris A.G. Effect of desloratdine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. J Allergy Clin Immunol 2002; 109: 6: 956-961.
Tashiro M., Duan X., Kato M. et al. Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin. Br J Clin Pharmacol 2008; 65: 811-821.
Church M.K., Maurer M., Simons F.E.R., Bindslev-Jensen C., van Cauwenberge P., Bousquet J., Holgate S.T., Zuberbier T. Risk of first-generation H1-antihistamines: a GA2LEN position paper. Allergy 2010; 65: 459–466.
Brost B.C., Scardo J.A., Newman R.B. Diphenhydramine overdose during pregnancy: lessons from the past. Am J Obstet Gynecol 1996; 175: 1376-1377.
Ito S., Blajchman A., Stephenson M. et al. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 1993; 168: 1393-1399.
Bousquet J., Cambell A.M., Canonica C.W. H1-receptor antagonists: structure and classification. Histamine and H1-Receptor antagonists in allergic disease. F.E.R. Simons (Ed.) Marcel Dekker, Ink. 1996; 91-116.
Bousquet J., Khaltaev N., Cruz A. et al. Allergic rhinitis and its impact on asthma (ARIA) update 2008 (in collaboration with World Health Organization, GA2LEN and AllerGen). Allergy 2008; 63: suppl. 86: 8-160.
Zuberbier T., Asero R., Bindslev-Jensen C. et al. EAACI/GA2LEN/EDF/WAO Guideline: Management of Urticaria. Allergy 2009; 64: 1427-1443.
Simons F.E. Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child. J Allergy Clin Immunol 1999; 104: 433-440.
Grimfeld A., Holgate S.T., Canonica G.W. et al. Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study. Clin Exp Allergy 2004; 34: 1665-1672.
Simons F.E. Safety of levocetirizine treatment in young atopic children: An 18-month study. Pediatr Allergy Immunol 2007; 18: 535-542.
O'Donnel B.F., Lawlor F., Simpson J. et al. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 2: 197-201.
Krapivnitsa i angiootek. Rekomendatsii dlya prakticheskikh vrachei. Rossiiskii natsional'nyi soglasitel'nyi dokument. M: Farmus Print Media 2007; 76-93.
Emel'yanov A.V., Trendeleva T.E. Terapevticheskie vozmozhnosti dezloratadina (eriusa) u bol'nykh allergicheskimi zabolevaniyami. Novye Sankt-Peterburgskie vrachebnye vedomosti 2002; 3: 78-83.
Goryachkina L.A., Moiseev S.V. Rol' dezloratadina (eriusa) v lechenii allergicheskikh zabolevanii. Klin farmakol i ter 2001; 10: 5: 79-82.
Grob J.-J., Auquier P., Dreyfus I, Ortonne J.-P. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life. Allergy 2009; 64: 605-612.
Klein P.A., Clark R.A. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999; 135: 12: 1522-1525.
Kochergin N.G. Antigistaminnye preparaty v dermatologii. Fel'dsh i akush 1990; 2: 50-52.
Kochergin N.G. i dr. Neopublikovannye dannye issledovanii avtorov.